Order Article Reprints

Sharratt M, Sands K, Portal EAR, Boostrom I, Mondeja BA, Rodríguez NM, Jones LC, Spiller OB. Defining Fluoroquinolone Resistance-Mediating Mutations from Non-Resistance Polymorphisms in Mycoplasma hominis Topoisomerases. Antibiotics. 2021; 10(11):1379. https://doi.org/10.3390/antibiotics10111379

Sharratt, Martin, Kirsty Sands, Edward A. R. Portal, Ian Boostrom, Brian A. Mondeja, Nadia M. Rodríguez, Lucy C. Jones, and Owen B. Spiller. 2021. "Defining Fluoroquinolone Resistance-Mediating Mutations from Non-Resistance Polymorphisms in Mycoplasma hominis Topoisomerases" Antibiotics 10, no. 11: 1379. https://doi.org/10.3390/antibiotics10111379

Sharratt, M., Sands, K., Portal, E. A. R., Boostrom, I., Mondeja, B. A., Rodríguez, N. M., Jones, L. C., & Spiller, O. B. (2021). Defining Fluoroquinolone Resistance-Mediating Mutations from Non-Resistance Polymorphisms in Mycoplasma hominis Topoisomerases. Antibiotics, 10(11), 1379. https://doi.org/10.3390/antibiotics10111379